Internal Medicine, Endocrinology, Diabetes, & Metabolism · Holland, MI
NPI
1053567743
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
650 S Waverly Rd Ste 100
Holland, MI, 49423
Phone (616) 312-2859
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
382 services
Medicare patients, 2024
169
Average age 69
Drug cost, 2024
$2.1M
3,268 prescriptions
Company payments, 2025
$15K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karl Nadolsky Jr. was code 99214 (office e&m - established), 151 times for 109 patients. In total Karl Nadolsky Jr. billed 382 services in 16 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 151 | 109 | $71.20 | $11K |
| 99204 Office E&M - New | Office | 57 | 57 | $89.22 | $5,086 |
| 95251 Test - Miscellaneous | Office | 52 | 39 | $25.73 | $1,338 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 45 | 39 | $12.54 | $564 |
| 99215 Office E&M - Established | Office | 20 | 19 | $113.53 | $2,271 |
By year: 2022 $23K for 439 services; 2023 $23K for 349 services; 2024 $22K for 382 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 77 | 53 | $9.57 | $737 |
| 82947 Clinical Chemistry | 27 | 22 | $3.88 | $105 |
Medicare prescription drug claims, 2024
In 2024, the drug Karl Nadolsky Jr. prescribed most often to Medicare patients was Levothyroxine Sodium, with 381 prescriptions and refills. In total Karl Nadolsky Jr. wrote 3,268 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 381 | 1,025 | 107 | $7,104 |
| Mounjaro Tirzepatide | 374 | 493 | 81 | $498K |
| Jardiance Empagliflozin | 227 | 436 | 55 | $241K |
| Pioglitazone Hcl Generic | 213 | 550 | 61 | $3,803 |
| Ozempic Semaglutide | 168 | 260 | 48 | $240K |
| Hydrocortisone Generic | 132 | 319 | 39 | $8,165 |
| Methimazole Generic | 113 | 302 | 42 | $2,447 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 94 | 227 | 31 | $112K |
| Metformin Hcl Er Metformin Hcl | 70 | 173 | 20 | $1,113 |
| Metformin Hcl Generic | 70 | 171 | 19 | $906 |
| Trulicity Dulaglutide | 60 | 76 | 18 | $72K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 53 | 126 | 22 | $28K |
| Rosuvastatin Calcium Generic | 49 | 137 | 18 | $1,344 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 48 | 117 | 22 | $59K |
| Humalog Kwikpen U-100 Insulin Lispro | 46 | 97 | 23 | $14K |
Brand drugs: 1,775 claims; generic drugs: 1,370 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl Nadolsky Jr. $15K ($15K in general payments such as food, travel and fees) from 20 companies. The largest payer was Corcept Therapeutics with $7,812.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 19 | $7,812 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $4,797 |
| Xeris Pharmaceuticals, Inc. | 9 | $710 |
| Novo Nordisk Inc NVO | 25 | $335 |
| Amgen Inc. AMGN | 13 | $334 |
| Madrigal Pharmaceuticals MDGL | 11 | $284 |
| Dexcom, Inc. DXCM | 8 | $248 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $217 |
| Medtronic, Inc. MDT | 3 | $159 |
| Insulet Corporation PODD | 2 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.